Cartalax

Public identity

Publication state

unpublished

Sequence

Ala-Glu-Asp

Available variants

Analytical boundary

Representative catalog purity: 99.2%

No active-batch certificate of analysis is currently published.

Purity figures shown here are representative catalog specifications, not lot-specific measurements.

Verify a certificate of analysis

Evidence inventory

Record state

reviewed records

Public records

17

Reviewed summaries

1

Verified citations

0

• Human study: 0
• In vivo: 2
• In vitro: 15
• Special category: 0
• Unclassified: 0

These counts describe linked records and review status. They do not establish efficacy, safety, or fitness for any use.

Open this product’s verified study library

Technical record

Molecular weight

390.4 Da

Sequence class

peptide

Appearance

Lyophilized Solid

Solubility

Water, PBS, or 0.9% NaCl

Mechanism record

Cartalax (Ala-Glu-Asp) is a Khavinson 3-residue chemical sequence bioregulator targeting chondrocytes and osteoblasts. It binds AT-rich DNA motifs in cartilage and bone gene promoter regions, stimulating proteoglycan synthesis, collagen type II expression, and chondrocyte differentiation. Also modulates osteoblast activity to support bone mineral density. Studied for age-related cartilage degeneration restoration.

Half-life record

~20–30 minutes (SubQ, plasma)

Recorded receptors

• Chondrocyte surface receptors
• osteoblast differentiation markers

External literature records

1. External literature record

Limitations and research boundary

Research use only. Not for human or veterinary use. Public catalog information is limited to chemical identity, analytical documentation, and external reference records.

External records are attributed references. Their presence does not convert a source-reported observation into a product claim.